We are monitoring the impact of COVID-19 on Latin America Lyme Disease Diagnostic Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5316
Share on
Share on

Latin America Lyme Disease Diagnostic Market Research Report - Segmented By Dark field microscopy, Diagnostic Technologies, End User & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Size, Share, Trends, Growth, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 5316
Pages: 145

Latin America Lyme Disease Diagnostic Market Size (2021 to 2026):

The Latin America Lyme Disease Diagnostic Market size is estimated to grow at a steady rate from 2021 to 2026.

The growing incidence of tick-borne diseases is expected to boost the Lyme disease diagnostic market growth during the review period in this region. Additionally, factors such as increasing government initiatives in improving the healthcare facilities and the rising focus of the key market players for the R&D to introduce new tests for the diagnosis of Lyme Diseases are further expected to drive the market. Additionally, the rising patient count suffering from Lyme Diseases due to the bacteria such as Borrelia and the usage of antibiotics in treating Lyme disease at an early stage is considered positive signs to the market's growth rate. The increasing need for enhanced clinical measures attributed to the diagnostic tests' blunders in recognizing Lyme diseases' early cases is estimated to favor the market during the forecast period. Availability of funds and investments by the key players to escalate the production potentiality, in turn, use for the improvements for Lyme diseases' diagnostics will act as a favor to the market growth.

However, the accuracy concerns of the disease diagnosis are significantly hampering the market growth. Huge R&D required and poor awareness among the people regarding the Lyme diseases are further restricting the market from unleashing its fullest growth potential.

This research report on the Latin America Lyme Disease Diagnostic Market has been segmented and sub-segmented into the following categories:

By Diagnostic Tests:

  • Darkfield microscopy
  • Urine antigen tests
  • lymphocytic transformation test
  • Serological tests
  • immunofluorescence staining
  • PCR tests

By Diagnostic Technologies:

  • Molecular diagnostics
  • Monoclonal antibodies
  • Flow cytometry
  • Brain MRI
  • Spinal tap
  • Echocardiogram
  • Electrocardiogram
  • Microdroplets

By End User:

  • Hospitals/clinics
  • Pharmaceutical Industries
  • Pathology labs
  • Research Institutes

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Based on the region, the rising focus of key players on enhancing their market presence across the globe is estimated to encourage the growth of the Latin American region. Since 2018, the Latin American Lyme Disease Diagnostics was hiking steadily, and the same is forecasted to happen during the forecast period. In this region, the Brazilian market is expected to have promising growth during the forecast period. The investments made by the government of Brazil are predicted to provide superior quality of clinical suspicions. Hence, the betterment of epidemiological information helps in the understanding of Lyme diseases.

The Brazilian Health System has come forward to create awareness in people about the Lyme-like borreliosis. The rising number of tick-borne infectious disease cases, accumulating vector-borne diseases, and intensifying healthcare expenses amplify industry growth. The rising demand for diagnostic tests and the increasing prevalence of new diagnostic tests for testing and identifying the diseases intensify industry growth. 

Noteworthy Companies dominating the Latin America Lyme Disease Diagnostics Market Profiled in the Report are Boulder Diagnostics, Immunetics Inc, GlaxoSmithKline Pharmaceuticals Ltd, Bio-Rad Laboratories, Alere Inc (ALR), Roche Diagnostics International Ltd, Graphene Frontiers, Covance Inc, Affymetrix Inc, Siemens AG, Baxter International Inc, Fresenius Medical Care AG & Co.

1. Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemiology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Diagnostic Tests

        5.1.1 Introduction           

        5.1.2 Serological tests    

                        5.1.2.1 ELISA (Enzyme-linked Immunosorbent Assay)

                        5.1.2.2 ELFA (Enzyme-linked Fluorescent Immunoassay)

                        5.1.2.3 Western Blot

        5.1.3 Lymphocytic transformation test  

        5.1.4 Immunofluorescence staining        

        5.1.5 PCR Analysis           

        5.1.6 Urine antigen tests              

        5.1.7 Darkfield microscopy         

        5.1.8  Y-o-Y Growth Analysis, By Diagnostic Tests              

        5.1.9  Market Attractiveness Analysis, By Diagnostic Tests            

        5.1.10  Market Share Analysis, By Diagnostic Tests           

                5.2 Diagnostic Technologies

        5.2.1 Introduction           

        5.2.2 Molecular diagnostics         

        5.2.3 Brain MRI 

        5.2.4 Spinal tap 

        5.2.5 Echocardiogram    

        5.2.6 Electrocardiogram

        5.2.7 Monoclonal antibodies      

        5.2.8 Flow cytometry     

        5.2.9 Gel micro droplets               

        5.2.10 Y-o-Y Growth Analysis, By Diagnostic Technologies             

        5.2.11 Market Attractiveness Analysis, By Diagnostic Technologies           

        5.2.12 Market Share Analysis, By Diagnostic Technologies            

                5.3 End Users                    

        5.3.1 Introduction           

        5.3.2 Hospitals / Clinics  

        5.3.3 Pharmaceutical Industries

        5.3.4 Pathology labs       

        5.3.5 Research Institutes             

        5.3.6 Y-o-Y Growth Analysis, By End Users           

        5.3.7  Market Attractiveness Analysis, By End Users        

        5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Diagnostic Tests

                        6.1.3.3 By Diagnostic Technologies

                        6.1.3.4 By End Users

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Diagnostic Tests

                        6.1.4.3 By Diagnostic Technologies

                        6.1.4.4 By End Users

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Diagnostic Tests

                        6.1.5.3 By Diagnostic Technologies

                        6.1.5.4 By End Users

                6.2 Brazil     

                6.3 Mexico 

                6.4 Argentina

                6.5 Rest of Latin America     

7. Strategic Analysis               

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                

                8.1 Abbott Laboratories       

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Siemens AG       

                8.3 GlaxoSmithKline Pharmaceuticals Ltd.    

                8.4 Fresenius Medical Care AG & Co.                      

                8.5 Baxter International Inc.                       

                8.6 Affymetrix Inc.  

                8.7 Immunetics Inc.

                8.8 Boulder Diagnostics                

                8.9 Roche Diagnostics International Ltd.                

                8.10 Canon U.S. Life Sciences                     

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  2. Latin America Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  3. Latin America Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  4. Latin America Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  5. Latin America PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  6. Latin America Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  7. Latin America Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  8. Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  9. Latin America Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  10. Latin America Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  11. Latin America Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  12. Latin America Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  13. Latin America Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  14. Latin America Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  15. Latin America Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  16. Latin America Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  17. Latin America Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  18. Latin America Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  19. Latin America Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  20. Latin America Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  21. Latin America Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  22. Brazil Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  23. Brazil Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  24. Brazil Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  25. Argentina Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  26. Argentina Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  27. Argentina Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  28. Mexico Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  29. Mexico Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  30. Mexico Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  31. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  32. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  33. Rest of Latin America Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample